Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway

W. Røysted, O. Simonsen, A. Jenkins, M. Sarjomaa, Y. Tveten, E. Ragnhildstveit, M.V. Svendsen, A. Kanestrøm, H. Waage, J. Ringstad (Skien, Fredrikstad, Bø in Telemark, Norway)

Source: Annual Congress 2012 - Management of severe respiratory infections
Session: Management of severe respiratory infections
Session type: Thematic Poster Session
Number: 2467
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Røysted, O. Simonsen, A. Jenkins, M. Sarjomaa, Y. Tveten, E. Ragnhildstveit, M.V. Svendsen, A. Kanestrøm, H. Waage, J. Ringstad (Skien, Fredrikstad, Bø in Telemark, Norway). Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway. Eur Respir J 2012; 40: Suppl. 56, 2467

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


One year analysis of hospital-treated, community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Epidemiology of community-acquired pneumonia (CAP)
Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults
Year: 2015



Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011


Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009
Source: Eur Respir J 2013; 41: 1141-1146
Year: 2013



Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Viral and mixed virus-bacteria community-acquired pneumonia (CAP) in hospitalized adults
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009

Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

Biomarkers in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012

Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Corticosteroids and community-acquired pneumonia
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


Discharge delay in patients with community-acquired pneumonia (CAP) treated with a pneumonia critical pathway
Source: Eur Respir J 2002; 20: Suppl. 38, 560s
Year: 2002

Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006

Atypical agents of community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Clostridium difficile infection following community-acquired pneumonia
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011

Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011